377 related articles for article (PubMed ID: 5158140)
1. Assay of serum abnormalities in uremic and dialysis patients. Evidence for depletion of vital substances in hemodialysis.
Quadracci LJ; Cambi V; Christopher TG; Harker LA; Striker GE
Trans Am Soc Artif Intern Organs; 1971; 17():96-101. PubMed ID: 5158140
[No Abstract] [Full Text] [Related]
2. [Nerve conduction velocity in chronic kidney failure].
Reichenmiller HE
Fortschr Med; 1973 Apr; 91(10):441-6. PubMed ID: 4633663
[No Abstract] [Full Text] [Related]
3. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
[TBL] [Abstract][Full Text] [Related]
4. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
Dirican M; Akca R; Sarandol E; Dilek K
J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
[TBL] [Abstract][Full Text] [Related]
5. [Electroencephalographic background activity and blood biochemistry data in patients with chronic renal failure during chronic hemodialysis].
Onozawa Y; Iwahashi K; Yoshimoto K; Munekata S; Yoshihara E; Aoki J; Kanoh Y; Akahoshi T
Rinsho Byori; 2010 Dec; 58(12):1169-75. PubMed ID: 21348236
[TBL] [Abstract][Full Text] [Related]
6. Platelet function in patients on long term peritoneal dialysis.
Lindsay RM; Friesen M; Koens F; Linton AL; Oreopoulos D; de Veber G
Clin Nephrol; 1976 Aug; 6(2):335-9. PubMed ID: 954241
[TBL] [Abstract][Full Text] [Related]
7. Hyperlipidemia in uremic children: response to peritoneal dialysis and hemodialysis.
Berger M; James GP; Davis ER; Jasper PM; Brouhard BH; Travis LB; Cunningham RJ
Clin Nephrol; 1978 Jan; 9(1):19-24. PubMed ID: 343952
[TBL] [Abstract][Full Text] [Related]
8. Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency.
Held H; Enderle C
Clin Nephrol; 1976 Sep; 6(3):388-93. PubMed ID: 136326
[TBL] [Abstract][Full Text] [Related]
9. The creatine kinase profile of a maintenance hemodialysis population: a possible marker of uremic myopathy.
Cohen IM; Griffiths J; Stone RA; Leech T
Clin Nephrol; 1980 May; 13(5):235-8. PubMed ID: 7398146
[TBL] [Abstract][Full Text] [Related]
10. Phagocytosis and neutrophil bactericidal capacity in patients with uremia.
Wierusz-Wysocka B; Wysocki H; Michta G; Wykretowicz A; Czarnecki R; Baczyk K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):589-94. PubMed ID: 6083931
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies on the effect of hemoperfusion and hemodialysis on the elimination of some uremic toxins.
Trznadel K; Walasek L; Kidawa Z; Lutz W
Clin Nephrol; 1978 Dec; 10(6):229-31. PubMed ID: 729215
[TBL] [Abstract][Full Text] [Related]
12. Middle molecule accumulation in uremia: an "extra uremic factor".
Oulès R; Emond C; Claret G; Branger B; Mion H; Mion C
Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
[TBL] [Abstract][Full Text] [Related]
13. Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients.
Khedmat H; Ahmadzad-Asl M; Amini M; Lessan-Pezeshki M; Einollahi B; Pourfarziani V; Naseri MH; Davoudi F
Transplant Proc; 2007 May; 39(4):1003-7. PubMed ID: 17524875
[TBL] [Abstract][Full Text] [Related]
14. New biological method for determination of the desintoxication rate of human plasma after dialysis.
Kovatchev D; Dimitrov H; Hristova P; Nenov D
Life Support Syst; 1983; 1 Suppl 1():191-4. PubMed ID: 6336408
[No Abstract] [Full Text] [Related]
15. Acute effects of hemodialysis on removal of intracellular solutes.
Nolph KD; Bass OE; Maher JF
Trans Am Soc Artif Intern Organs; 1974; 20 B():622-7. PubMed ID: 4476100
[No Abstract] [Full Text] [Related]
16. Platelet factor 3 in normal subjects and patients with renal failure.
Rabiner SF; Hrodek O
J Clin Invest; 1968 Apr; 47(4):901-12. PubMed ID: 5641625
[TBL] [Abstract][Full Text] [Related]
17. [Variations in prolactinemia in 26 uremic subjects treated by periodic hemodialysis].
Deambrogio P; Vanni M; Aleo AG
Minerva Med; 1985 Apr; 76(17-18):847-9. PubMed ID: 4000528
[TBL] [Abstract][Full Text] [Related]
18. The dynamics of serum myoinositol concentration changes during haemodialysis and peritoneal dialysis.
Trznadel K; Walasek L; Waldemar L
Acta Med Pol; 1977; 18(1):55-61. PubMed ID: 855681
[No Abstract] [Full Text] [Related]
19. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
20. Protein in the diets of dialyzed and non-dialyzed uremic patients. Study with nitrogen-labeled urea.
Smith EB; Hill PA
J Am Diet Assoc; 1972 May; 60(5):389-93. PubMed ID: 5018368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
